Bovine ephemeral fever (BEF) is an infectious, arthropod-born viral disease has economic importance in cattle and buffaloes. Vaccination is widely used to control and prevent BEF disease. This study aimed to prepare an inactivated BEF vaccine using adjuvant that was applied in two different protocols (one dose and two doses one month apart). The prepared vaccine was sterile and safe. It was found that a single dose of the vaccine induced protective neutralizing serum antibody titer from 2nd week post vaccination (PV), reached highest titer at 10th week PV and persisted in this protective titer until 34 weeks PV using SNT and confirmed using ELISA, however boostering of animals 4 weeks post preliminary vaccination increased the titer of the protective neutralizing antibodies and its time duration to 44 weeks PV. Thus, in order to provide immunity that will last the entire season it is recommended that the vaccine should be administered short time before the onset of BEF season (summer season).
INTRODUCTION
Bovine ephemeral fever (BEF) is an infectious, arthropod-born viral disease of cattle and waterbuffaloes characterized by sudden onset of fever, depression, difficulty swallowing, serous ocular and nasal discharge, dyspnea, stiffness and lameness (Nandi and Negi, 1999) . Various complications could occur as pneumonia, subcutaneous emphysema, mastitis, hind-quarter paralysis and bull infertility for up to six months (Radostits et al., 2000) . Financial effects ascribed to BEF included intense drop in milk production, abortion, expenses of care of infected animals and immunization of healthy flocks and disturbance of routine stock handling, care and marketing (Coetzer et al., 1994) . The causative BEF virus was characterized in genus Ephemerovirus in the family Rhabdoviridae and has bullet or cone-shaped morphology, single stranded negative-sense RNA genome (14,900 nucleotides) and five structural proteins involving a nucleoprotein (N), a polymerase-associated protein (P), a matrix protein (M), a large RNAdependent RNA polymerase (L) and a glycoprotein (G) spreading over the viral envelope against which neutralizing antibodies are directed (Walker et al., 1991) . The virus is transmitted by hematophagous insects that it has been isolated from mosquitoes and Culicoides biting midges (Kirland, 1995; Mellor, 1996) . All perceived episodes of BEF infection have regular appearance which principally happened in late summer and autumn and happen over an expansive range of tropical, subtropical and temperate countries in Africa, Asia, Middle East and Australia (St George, 1988) . In Egypt, several outbreaks of BEF have been happened in summer of rehashed years (Al-Gaabary et al., 2005 ; Davies et al., 1993; ElBagoury et al., 2014; Hassan, 2000; Kawther and Wahid, 2011; Zaghawa et al., 2002) . Vaccination is widely used to control and prevent BEF disease. Local live and inactivated BEF vaccines were prepared and successfully used to give good protection rates (Daoud et al., 2001a; Daoud et al., 2001b) . However, inactivated BEF vaccine showed short duration of protection among vaccinated animals and repeated occurrence of BEF among cattle and buffaloes at different Egyptian provinces was registered (Hassan, 2000) . Recently, inactivated vaccines have used water-in-oil-inwater adjuvant that shown to elicit a stronger and longer lasting neutralizing antibody response, depend on booster programs (Aziz-Boaron et al., 2013) .
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We have organized our work to prepare an inactivated BEF vaccine using as adjuvant then to appraise the duration of immune response in animals taking the vaccine by two particular traditions (one and two doses).
MATERIAL AND METHODS

Bovine Ephemeral Fever (BEF) virus strain:
It was isolated from Toukh Tambasha; Monofia Governorate, Egypt during the outbreak that occurred in summer 2000 (Soad et al., 2001 (Macpherson and Stocher, 1962) . These cells were used for virus propagation and titration and also for SNT
Experimental Calves:
Fourteen male calves (local breed) aged between 9-10 months old about 300 kg body weights were used for evaluation of the prepared inactivated BEF vaccine with Montanide ISA206 adjuvant.
Vaccine formulation:
BEF virus was inoculated onto a monolayer BHK-21 cell line that harvested at over 70% cytopathic effect after 30-35 h, and then it was purified by centrifugation at 3000 rpm for 20 minutes to remove cell debris (Killington et al., 1996) . Titer of the tissue culture adapted virus was estimated on BHK21 cell line (Reed and Muench, 1938) and its antigenicity was titrated using Complement Fixation Test (CFT), ((Traub and Manso, 1944) . The seed BEF virus had a titer of 10 8 TCID50/ml and 64 using infectivity titration and CFT, respectively. It was inactivated by Binary ethylenimine (BEI) and the vaccine formulation was carried out where the oil phase consisted of Montanide ISA 206, mixed as equal parts of an aqueous and oil phase weight/ weight, and mixed to make water-in-oil-in-water suspension (Barnett et al., 1998) .
Quality control of the prepared vaccine:
Sterility and safety was evaluated for the prepared inactivated BEF vaccine according to (Code of Federal Regulation of USA, 1986) . Sterility test was applied to confirm that the prepared vaccine was free from bacterial and fungal contamination using nutrient agar, thioglycolate broth (for bacterial detection) and Sabouraud's dextrose agar (for fungal detection). Safety of the inactivated BEF virus before addition of adjuvant was applied on tissue culture and the safety of the prepared vaccine after adjuvant was applied by injection of 20 ml (10X dose) of the vaccine in calves by subcutaneous (S/C) route.
Experimental design:
Calves were used for evaluation of the prepared inactivated BEF vaccine with Montanide ISA206 adjuvant as follow: Group (1): Five calves vaccinated with 2ml/animal (S/C) of the prepared oil vaccine as one dose. Group (2): Five calves vaccinated with 2ml/animal (S/C) of the prepared oil vaccine and boostered similarly after one month. Group (3): Two calves were kept as control without vaccination. Group (4): Two calves were used in safety test of the prepared vaccine. Sera from animals in groups (1), (2) and (3) were collected for 48 weeks and used to measure the variance in efficacy and duration of immunity in vaccinated calves using SNT and ELISA test.
Serum neutralization test (SNT):
SNT was performed using the micro-technique to detect neutralizing antibodies against BEF virus. The antibody titer was estimated as the reciprocal of the final serum dilution which neutralized and inhibited the CPE of 100 TCID50 of BEF virus (Mellor, 2001 ).
Enzyme Linked Immunosorbent Assay
(ELISA): BEF antigen was prepared from infected BHK -21 cells and concentrated by PEG (6000) according to (Wagner et al., 1969) , then used in ELISA to estimate the specific antibodies of BEF virus (Zakrzewski et al., 1992) .
RESULTS
Sterility and safety of the vaccine:
The prepared vaccine was free from aerobic and anaerobic bacteria and fungi. It was also safe and gave satisfactory results indicated by absence of cytopathic effect on tissue culture, and absence of local and systemic reactions on inoculated calves with no rise in body temperature.
Humeral immune response:
Evaluation of the humeral immune response in vaccinated calf groups using SNT showed that protective neutralizing serum antibody titer (1.2) started from 2nd week PV, reached highest titer at 10th week PV and persisted in this protective titer until 34 weeks PV for group (1) of calves vaccinated with one dose of the prepared vaccine.
For group (2) of calves vaccinated with two doses of the prepared vaccine one-week interval, protective neutralizing serum antibody titer started from 2nd week PV, reached the highest level at 12th week PV and persisted in the protective level until 44 weeks PV. These results were shown in table (1) and figure (1) in comparison to that of the calves kept as control non-vaccinated Group (3). Evaluation of the humeral immune response in vaccinated calf groups using ELISA showed that serum antibody level started to increase from the 2nd week PV, reached highest level at 10th week PV and persisted in this satisfactory level until 34 weeks PV for group (1) of calves. For group (2), calf's serum antibody level started to increase from 2nd week PV, reached the highest level at 12th week PV and persisted in the satisfactory level until 48 weeks PV. These results were shown in table (2) and figure (2) in comparison to that of the calves kept as control non-vaccinated Group (3).
DISSCUSSION
In Egypt, BEF emerged as a major viral disease of cattle and many outbreaks have been occurred. The economic impact of BEF was not estimated until the epidemic of 2000 (Zaghawa et al., 2002 ) and the frequent recurrence since then which coasted a hundred million of Egyptian pounds. In order to preclude production losses caused by BEF, vaccination of cattle particularly dairy and feedlot herds and valuable breeding stock was carried out to ensure a high level of immunity in the offending season when vector arthropods are likely to be most abundant. Advancement in the decade of ready-to-formulate oil adjuvant has added a new dimension to vaccine formulation. Oil adjuvant (water-in-oil-in-water) contains all components necessary to produce complex, low viscosity, stable emulsion which safely stimulates rapid and protective immune response, in addition this adjuvant has been found to stimulate longer immunity compared to aluminum salts adjuvant (Hsieh et al., 2006) .
In our study an inactivated BEF vaccine was prepared using Montanide ISA206 (water-in-oilin-water) as an adjuvant. Sterility of the prepared vaccine was proved being free from bacterial and fungal contamination (Code of Federal Regulation of USA, 1986). The prepared vaccine proved to be safe in both tissue culture and calves. In tissue culture, inoculated BHK21 cell line showed no cytopathic effect, and the safety in calves gave also no rise in body temperature and no clinical abnormalities (Henderson, 1970) .
Comparative evaluation of the humeral immune response in vaccinated calves showed that protective neutralizing serum antibody titer (1.2) started from 2nd week post vaccination (PV), reached highest titer at 10th week PV and persisted in this protective titer until 34 weeks PV for group (1) of calves vaccinated with one dose of the prepared vaccine. The previous results were assessed in comparison to that of the control nonvaccinated calves using SNT that were confirmed using ELISA. These results came in agreement with that of Barnett et al. (1996) ; Cox et al. (2003); Hunter (1996); Patil et al. (2002) who suggested that vaccines adjuvanted with Montanide ISA 206 can promote longer lasting immunity than conventional vaccines adjuvanted with Alhydragel in ruminant persisted for at least 6 months' post vaccination.
In the other side, protective neutralizing serum antibody titer started from 2nd week PV, reached the highest level at 12th week PV and persisted in the protective level until 44 weeks PV for group (2) of calves vaccinated with two doses of the prepared vaccine one-week interval. The previous results were assessed in comparison to that of the control non-vaccinated calves using SNT that were confirmed using ELISA. These results came in agreement with that of Theodoridis et al. (1973) who used emulsions of BEF virus of both low and high passage in Freund's incomplete mineral oil adjuvant and noticed that this vaccine could induced high neutralizing antibodies in vaccinated cattle which could be detectable for at least a year.
These results came in agreement also with that of Cameron et al. (1987) who reported that the booster BEF oil emulsion vaccine or double injection give very good antibody response and high titer than single injection.
This study reflected that single dose of inactivated BEF vaccine on Montanide oil ISA 206 (water-in-oil-in-water) adjuvant gave a long immunity for not less than 8 months PV but when these animals were bostered by a second dose 4 weeks post preliminary vaccination, the titer of the neutralizing antibodies and its time duration were increased to reach 44 weeks PV. Thus, in order to provide immunity that will last the entire season it is recommended that the vaccine should be administered a short time before the onset of BEF season (summer season). Published by the office of the federal register national archives and Record administration. Animal and animal products. Coetzer, J.A.W., Thomson, R.G., Tustin, R.C., Kriek, N.P.J., 1994. In infectious diseases of
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